Salacir Tablets USP 500 mg Manufacturer

Salacir Tablets USP 500 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Salacir Tablets USP 500 mg Manufacturer product packaging

Salacir Tablets USP 500 mg | Manufacturer

Product image for Salacir Tablets USP 500 mg Manufacturer; contract manufacturing, oem & quality control.

Product Information

Generic NameSalacir
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaUSP
Product TypeTablet
CategoryAnti-inflammatory drugs – 5-ASA
Subcategory5-ASA
Active IngredientSalacir
Strength500 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAnti-inflammatory drugs – 5-ASA

Medicine Details & Safety

Short DescriptionHealthy Life Pharma invites contract and third-party manufacturing enquiries for Salacir Tablets USP 500 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.
Approved Uses / Indications1. Relief of pain and functional stiffness in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. 2. Management of acute painful musculoskeletal disorders, tenosynovitis, lumbago, dentalgia, and post-traumatic injury.
Full Description

Healthy Life Pharma invites contract and third-party manufacturing enquiries for Salacir Tablets USP 500 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.

Product technical specifications

Generic nameSalacir
CompositionSalacir
Strength500 mg
CategoryAnti-inflammatory drugs – 5-ASA
PharmacopoeiaUSP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Manufacturing capabilities and infrastructure

For Salacir Tablets USP 500 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.

Quality control and assurance

Request the approved finished-product specification for Salacir Tablets USP 500 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.

Primary and secondary packaging

The catalogue pack for Salacir Tablets USP 500 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.

Contract manufacturing and private label

Submit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution.
Dosage InstructionsAdminister orally with a full glass of water, preferably with or immediately following meals to minimize gastric irritation. Do not exceed the maximum prescribed daily dosage. Use the lowest effective dose for the shortest treatment duration necessary.
Side EffectsCommon: Epigastric discomfort, dyspepsia, heartburn, nausea, abdominal pain. Uncommon: Dizziness, headache, mild diarrhea, flatulence, constipation. Rare: Peptic ulceration, gastrointestinal hemorrhage, elevated transaminases, hypersensitivity rash.
Warnings and PrecautionsGastrointestinal Safety: Long-term administration can lead to gastric mucosal erosion, ulceration, or bleeding. Cardiovascular & Renal Caution: Use with caution in patients with preexisting hypertension, congestive heart failure, or renal compromise. Monitor renal parameters periodically.
Contraindications1. Known hypersensitivity to Salacir, aspirin, or other NSAIDs.
2. Active peptic ulcer disease, gastrointestinal hemorrhage, or history of perforation.
3. Severe heart failure (NYHA Class III-IV), severe hepatic cirrhosis, or advanced renal failure.
4. Third trimester of pregnancy.
Drug Interactions1. Anticoagulants & Antiplatelets (Warfarin, Clopidogrel): Increased risk of serious GI bleeding.
2. ACE Inhibitors, ARBs & Diuretics: Attenuated antihypertensive efficacy and increased nephrotoxicity risk.
3. Methotrexate & Lithium: Reduced renal clearance causing elevated serum concentrations and toxicity.

Frequently Asked Questions

QuestionAnswer
Can I request third-party manufacturing for Salacir Tablets USP 500 mg?Submit your brand, quantity and packaging requirements for manufacturing feasibility review.
Which pharmacopoeial standard applies for Salacir Tablets USP 500 mg?The source specification is USP; confirm the required standard before contracting.
What quality tests are applicable for Salacir Tablets USP 500 mg?Request the approved finished-product specification and batch testing plan.
Can packaging be customized for Salacir Tablets USP 500 mg?Submit artwork and pack requirements for technical and regulatory review.
How do I request a manufacturing quotation for Salacir Tablets USP 500 mg?Provide forecast volume, target market, strength and packaging requirements.

Product Hashtags

#Salacir#Manufacturer#PharmaB2B

Related Products

Latest Posts